I
Immunovant, Inc. (IMVT)
NMS – Real Time Price. Currency in USD
42.60
+1.67 (4.08%)
At close: Aug 12, 2026, 4:00 PM EDT
42.60
0.00 (0.00%)
After-hours: Aug 12, 2026, 4:22 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
42.60
+1.67 (4.08%)
At close: Aug 12, 2026, 4:00 PM EDT
42.60
0.00 (0.00%)
After-hours: Aug 12, 2026, 4:22 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Cash reserves $797.8M barely cover the upcoming debt maturities $0.0
Total current assets $851.2M exceed Total current liabilities $117.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 7.27 | 6.05 | 10 | |
| Quick ratio | 7.27 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -1M | -231K | -377K | -409K | -394K |
| Operating Income | -208M | -270M | -438M | -533M | -566M |
| Net Income | -211M | -259M | -414M | -506M | -538M |
| EBITDA | -207M | -270M | -438M | -532M | -566M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 0.18 | 1.5 |
| Next quarter | N/A | -17.27 | 1.0 |
| Current year | N/A | -4.06 | 1.0 |
| Next year | N/A | 1.3 | 2.0 |
| Weighted average score | 1.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -3.62 | 6.44 | -2.96 | 4.3 |
| Y/Y | 999 | -27.03 | 3.8 | 14.23 | 5.8 |
| 3y average | 999 | -34.87 | -18.85 | -32.51 | 3.3 |
| 5y average | 999 | -37.01 | -18.66 | -40.38 | 3.3 |
| Weighted average score | 4.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |